Literature DB >> 2986045

The morphogenesis of stereotyped behavior induced by the dopamine receptor agonist apomorphine in the laboratory rat.

H Szechtman, K Ornstein, P Teitelbaum, I Golani.   

Abstract

The seemingly unrelated stereotyped locomotor "acts" reported in the literature to be produced by apomorphine in rats are shown to be composites, whose form and sequence are determined by the particular values of a few component variables which form a common denominator in each of the behaviors. Three variables, continuous snout contact, forward progression and turning, account for much of the behavior. In the course of the drug's action these emerge in succession and vary in amount, the latter two successively reaching a peak and subsiding. The interaction between forward progression and turning yields in sequence, forward walking, circling, revolving, tight pivoting and finally side-to-side movements of the forequarters around the relatively stationary hindquarters. Later behaviors in this list are gradually incorporated into the sequence as earlier ones are eliminated. The course of change in forward progression and turning is also reflected in changes in the sequence and in the direction of stepping of each of the four legs. The order in which the behavior unfolds under the drug is opposite to that manifested in ontogeny and in recovery from lateral hypothalamic damage, suggesting that at the particular high dose used, apomorphine is acting not only to activate the behavior but also to shut it down.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986045     DOI: 10.1016/0306-4522(85)90143-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.

Authors:  D Eilam; H Talangbayan; G Canaran; H Szechtman
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats: A.M. Ernst. Psychopharmacologia (Berl.) 10, 316-323 (1967)

Authors:  T W Robbins; D de Wied
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Coordination of steering in a free-trotting quadruped.

Authors:  Eyal Gruntman; Yoav Benjamini; Ilan Golani
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2006-12-05       Impact factor: 1.836

Review 4.  Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model.

Authors:  J Wickens
Journal:  J Neural Transm Gen Sect       Date:  1990

5.  Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Unilateral hemispherectomy at adulthood asymmetrically affects motor performance of male Swiss mice.

Authors:  Danielle Paes-Branco; Yael Abreu-Villaça; Alex C Manhães; Cláudio C Filgueiras
Journal:  Exp Brain Res       Date:  2012-02-25       Impact factor: 1.972

Review 7.  Contributions of Philip Teitelbaum to affective neuroscience.

Authors:  Kent C Berridge
Journal:  Behav Brain Res       Date:  2011-10-25       Impact factor: 3.332

8.  GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-12-18       Impact factor: 4.530

9.  Effect of the dopamine receptor agonist apomorphine on sensory input.

Authors:  H Szechtman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

10.  Freedom of movement and the stability of its unfolding in free exploration of mice.

Authors:  Ehud Fonio; Yoav Benjamini; Ilan Golani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.